2-{2-[4-(4-Fluorophenyl)piperazin-1-yl]-2-oxoethyl}-6-(morpholin-4-yl)-4-phenylpyridazin-3(2H)-one

AYDIN, ABDULLAH; Sukuroglu, MURAT; AKKURT, MEHMET; BÜYÜKGÜNGÖR, ORHAN

doi:10.1107/s1600536811005071

2-{2-[4-(4-Fluorophenyl)piperazin-1-yl]-2-oxoethyl}-6-(morpholin-4-yl)-4-phenylpyridazin-3(2H)-one

Atıf İçin Kopyala

AYDIN A., Sukuroglu M. K., AKKURT M., BÜYÜKGÜNGÖR O.

ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, cilt.67, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 67
Basım Tarihi: 2011
Doi Numarası: 10.1107/s1600536811005071
Dergi Adı: ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Gazi Üniversitesi Adresli: Evet

Özet

In the title compound, C26H28FN5O3, the morpholine ring adopts a chair conformation. The piperazine ring is puckered [Q(T) = 0.5437 (15) angstrom, theta = 8.89 (15) and phi = 357.2 (11)degrees]. The 1,6-dihydropyridazine ring makes dihedral angles of 28.03 (7) and 77.46 (7)degrees with the phenyl and benzene rings, respectively. In the crystal, molecules are linked along the c axis by C-H center dot center dot center dot O interactions and are flattened parallel to the ac plane. C-H center dot center dot center dot pi interactions also contribute to the stability of the structure.